InTouch
The new ISPE GAMP® Guide: Artificial Intelligence provides a comprehensive, state-of-the-art best practice framework to efficiently and effectively achieve high-quality AI-enabled...
Eric Staib
Syneos Health
Vice President, Corporate Quality
Eric Staib is Vice President of Corporate Quality at Syneos Health. He has more than 25 years of pharmaceutical industry experience in various GXP areas, including direct experience and leadership for quality systems development/management, software quality engineering, information technology, and computer systems validation/assurance (CSV/CSA). He holds a BS in biology from James Madison University, an MS in quality assurance and regulatory affairs from Temple University, a graduate certificate in project management from Lehigh University, and an MBA in pharmaceutical management from Drexel University. Eric was a previous Chair of the GAMP Americas Steering Committee for ISPE, and currently chairs a Software Automation and Artificial Intelligence Special Interest Group (SIG), in addition to serving as Secretary of the AI CoP Steering Committee. He has presented at numerous industry conferences in addition to having published and contributed to several concept papers, magazine and journal articles, and good practice guides; including the 2nd edition of GAMP5. Eric has been an ISPE member since 2001 and is a recognized GAMP instructor.
Related Articles
iSpeak Blog
A strategic goal of the new ISPE GAMP® Guide: Artificial Intelligence is to establish the overall “what” layer regarding development and use of AI-enabled computerized systems while also providing a comprehensive, state-of-the-art best practice framework to efficiently and effectively achieve high-quality AI-enabled computerized systems in regulated life science areas. It bridges established GAMP...
iSpeak Blog
The new ISPE GAMP® Guide: Artificial Intelligence provides a comprehensive, state-of-the-art best practice framework to efficiently and effectively achieve high-quality AI-enabled computerized systems in regulated life science areas. It bridges established GAMP concepts with...
iSpeak Blog
It is an exciting time in life sciences. Many companies have focused initial artificial intelligence/machine learning (AI/ML) adoption efforts on developing and implementing ML trained algorithms, which necessitate following a controlled approach such as the GAMP® 5 ML Sub-System methodology shown below. This blog highlights key artifacts and considerations when implementing AI/ML for GxP use...
Features
This article explores life-cycle activities for machine learning (ML) within regulated life sciences. It positions and contextualizes the life cycle and management of the machine learning subsystem or components within a wider system life cycle. It also gives general descriptions and guidance illustrated by a case study demonstrating a machine learning application to medical image recognition,...